Presented by
Management Forum
Explore how GMP impacts an organisation’s finances – does it hinder innovation and add costs, or unlock potential and boost financial health?
Are you aware of how the GMP requirements impact the financials of an organisation?
How can you provide financial justification for a system or process which helps meet compliance?
Does being compliant save or cost a company money?
Good Manufacturing Practice (GMP) in the pharmaceutical industry is often seen as being stringent and heavily regulated. Company finance plays a role in being compliant. But what if we turn this around? How does compliance play a role in a company’s financial health?
Participants will learn about how being compliant impacts the three key financial statements – balance sheet, income statement and statement of cashflows. They will also learn how compliance can be used to improve financial health.
Pharmaceutical regulations and guidelines such as International Council for Harmonisation (ICH) and Pharmaceutical Inspection Co-operation Scheme (PIC/S) form a critical pathway for pharmaceutical companies. These are stringent requirements with one key goal – patient safety.
As regulations and guidelines are introduced, organisations work hard to stay compliant. Change is the only constant (as the saying goes), with balancing costs and compliance becoming a challenge.
In days of fast technological advances, are we choosing new shiny solutions and compromising efficiency? How do you know if a new machine, equipment or software solution will be both compliant and cost effective compared to the current state?
Leadership team members across the organisation work with regulations and guidelines daily, however it is rare for them to know how their decisions impact the financial position of a business.
In this course, we explore how the elements of GMP impact the financials of an organisation. We also consider whether GMP requirements hold back innovation and increase costs, or do they unlock potential and support financial health of a business?
Some key elements we consider include:
This course introduces you to tools and techniques you can use to prepare, produce or participate in activities involving compliance whilst balancing costs.
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.
Attending this session will help deepen your knowledge and support your understanding on how the GMP requirements benefit an organisation's financial performance.
The benefits of attending this session include:
This session is designed for senior life science professionals involved with GMP requirements either directly or indirectly.
The stakeholders are typically from executive and management roles responsible for and involved in decision making and striving to balance financial goals with compliance and quality requirements.
Other interested stakeholders not directly involved with compliance or quality include:
Jitan Bhudia is a highly accomplished Pharmaceutical Consultant with extensive expertise in Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and regulatory compliance within the pharmaceutical industry. With a career spanning over two decades, Jitan has a proven track record of leading business operations, ensuring regulatory compliance, and driving commercial success in pharmaceutical manufacturing and distribution.
As the co-founder of jarmatrixpharma.com, a site dedicated to help organisations “manage knowledge”, Jitan has provided specialized consulting and tailored training solutions for pharmaceutical manufacturing. He has designed and implemented Quality and Document Management Systems, supported regulatory audits, and worked closely with industry stakeholders to ensure compliance with stringent pharmaceutical regulations. His ability to develop cost-effective compliance solutions and deliver expert training on quality management strategies has positioned him as a trusted advisor in the field.
Previously, Jitan served as the Owner, Director, and Head of Production at Percuro Medica Limited, where he played a pivotal role in establishing and expanding the company. Under his leadership, the company gained essential licenses from the MHRA and the Home Office for the manufacture and distribution of controlled drugs. His expertise in facility design, validation, and risk management helped secure major contracts with pharmaceutical companies.
With his deep industry knowledge, regulatory expertise, and business acumen, Jitan continues to support pharmaceutical organizations in navigating complex compliance landscapes, optimizing quality systems, and achieving operational excellence.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
Please contact us for pricing if you are interested in booking 5 or more delegates
6 June 2025
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 15700
Until 02 May
Not ready to book yet?
for 7 days, no obligation
24 October 2025
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 15701
Until 19 Sep
Not ready to book yet?
for 7 days, no obligation
6 February 2026
Live online
09:00-16:30 UK (London) (UTC+00)
10:00-17:30 Paris (UTC+01)
04:00-11:30 New York (UTC-05)
Course code 15702
Until 02 Jan
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: